FDA approves Augmentin ES-600[TM] for children at risk for repeat middle ear infections. (New Products)

Source :: Pediatric Nursing. Nov-Dec, 2002, Vol. 28 Issue 6, p636, 1 p.
Publication Year :: 2002
Abstract: GlaxoSmithKline has announced that Augmentin ES-600[TM] (amoxicillin/clavulanate potassium) Powder for Oral Suspension is now available in drug stores throughout the United States. The availability of Augmentin ES-600 coincides with the [...]

Subjects :: Augmentin ES-600 (Medication) -- Usage
Augmentin ES-600 (Medication) -- Licensing agreements
Ear diseases -- Drug therapy
Otitis media -- Drug therapy
Amoxicillin -- Usage
Clavulanate -- Usage

Tools